Portfolio map · Private equity · Netherlands

Forbion Capital Partners portfolio map

74 startups Forbion Capital Partners has backed in rounds we track, since 2007, grouped by their main sector. Together they have raised $10B; Forbion Capital Partners led at least one round in 8 of them. The biggest sector is Biotech, with 55 companies.

74startups backed
4sectors
$10Braised between them
Biotechbiggest sector

Forbion Capital Partners's investor profile

Biotech

55

+31 more

Pharma

10

Healthtech

6

Agtech

3

Segment by segment

Biotech

55 startups · $7.5B raised

  1. Dyne TherapeuticsDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.United States$828M
  2. Verdiva BioVerdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024.United Kingdom$601M
  3. CellCentricCellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.United Kingdom$525M
  4. New Amsterdam PharmaNew Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.Netherlands$453M
  5. Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
  6. Beacon TherapeuticsBeacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023, dedicated to saving and restoring vision United States$247M
  7. Marea TherapeuticsMarea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.United States$190M
  8. AM PharmaAM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands.Netherlands$189M

Pharma

10 startups · $1.9B raised

  1. MapLight TherapeuticsMapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.United States$523M
  2. OMass TherapeuticsOMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule meUnited Kingdom$442M
  3. ABAiolos BioAiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.United States$245M
  4. Solstice OncologySolstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.United States$225M
  5. Protego BiopharmaProtego Biopharma is a California-based biotechnology company that researches and develops small-molecule therapeutics for the treUnited States$130M
  6. Sling TherapeuticsSling Therapeutics is a private biopharmaceutical company based in Ann Arbor, Michigan.United States$123M
  7. Rampart BioscienceRampart Bioscience is a private biotechnology company focused on developing non-viral, DNA-based gene medicines for genetically drUnited States$85M
  8. Inversago PharmaInversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonistsCanada$69M

Healthtech

6 startups · $555M raised

  1. Orbis MedicinesOrbis Medicines is a biotechnology company based in Copenhagen, Denmark, with an additional presence in Lausanne, Switzerland.Denmark$187M
  2. Engrail TherapeuticsEngrail Therapeutics is a clinical-stage pharmaceutical company based in San Diego, California, founded in 2019.United States$157M
  3. Enterprise TherapeuticsEnterprise Therapeutics Ltd is a UK-based biopharmaceutical company founded in 2014, located at the Sussex Innovation Centre in Brighton.United Kingdom$80M
  4. OxularOxular Limited, based in Oxford, United Kingdom, is a clinical-stage biotechnology company focused on developing innovative drug-dUnited Kingdom$58M
  5. PMPathway Medical TechnologiesPathway Medical Technologies develops, manufactures and markets medical devices for the treatment of arterial disease.United States$52M
  6. OMEICOS TherapeuticsOMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.-$19M

Agtech

3 startups · $238M raised

  1. Tropic BiosciencesTropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.United Kingdom$175M
  2. GenominesGenomines is a deeptech and biotechnology startup based in Paris, France, with operations in Saclay.France$45M
  3. SOLASTA BioSOLASTA® Bio is an agri-biotechnology company based in Glasgow, Scotland, founded in May 2020.United Kingdom$19M

How this map is made. Every startup here has raised money in a round we track that names Forbion Capital Partners as an investor, the first in 2007. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
VC firm · NetherlandsTrue Ventures153 startups · 12 sectors · $6.1BCorporate investor · NetherlandsRabobank75 startups · 10 sectors · $9.8BAccelerator · NetherlandsRockstart62 startups · 12 sectors · $237MVC firm · NetherlandsEIT InnoEnergy58 startups · 8 sectors · $1.4BGovernment fund · NetherlandsFMO42 startups · 5 sectors · $3.0BVC firm · NetherlandsMaven 11 Capital38 startups · 4 sectors · $856M

Raising from investors like Forbion Capital Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps